NeuroPace (NPCE) Cost of Revenue (2020 - 2026)

NeuroPace's Cost of Revenue history runs 7 years deep, the most recent figure standing at $4.0 million for Q1 2026.

• On a quarterly basis, Cost of Revenue fell 22.42% year-over-year to $4.0 million in Q1 2026; TTM through Mar 2026 was $21.6 million, a 1.8% increase from a year earlier, with the FY2025 full-year figure at $22.8 million, up 9.34% from the prior year.
• Cost of Revenue eased to $4.0 million in Q1 2026 per NPCE's latest filing, from $6.0 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $6.2 million in Q3 2025 and bottomed at $2.7 million in Q2 2022.
• The 5-year median for Cost of Revenue is $4.5 million (2023), against an average of $4.6 million.
• Across the five-year window, Cost of Revenue surged 65.98% in 2023 and decreased 22.42% in 2026, its largest moves.
• Year by year, Cost of Revenue stood at $4.0 million in 2022, then climbed by 12.07% to $4.5 million in 2023, then advanced by 18.16% to $5.3 million in 2024, then increased by 13.87% to $6.0 million in 2025, then sank by 33.11% to $4.0 million in 2026.
• Per Business Quant, the three latest NPCE Cost of Revenue figures stand at $4.0 million (Q1 2026), $6.0 million (Q4 2025), and $6.2 million (Q3 2025).